Who We Are

At Strateos, our mission is to turn biology into an information technology, driven by data, computation, and high-throughput robotics with the goal of substantially advancing drug discovery. Our team brings together deep expertise in biology, automation, and software engineering to set new standards for the way research is done.

Leadership Team

Strateos's experienced and diverse leadership team deeply believe in the core mission to turn biology into an information technology. Together they form a highly efficient team spanning biology, automation, and software engineering that guide the fantastic team of people that is Strateos.

Mark Fischer-Colbrie

President, CEO

Mr. Fischer-Colbrie became President and CEO of Strateos in June 2019. He has more than 30 years of experience in launching novel diagnostics, medical devices, therapeutics and high technology for growth companies, building from start-up through IPO and into high revenue levels. Prior to joining Labcyte, Mark was President and CEO of Labcyte for over ten years.

Daniel Sipes

SVP of Operations and Strategy / San Diego Site Head

Daniel Sipes joined Strateos in March 2019 to lead the San Diego operations. Prior to Strateos, he was the Director of Advanced Automation Technologies at the Genomics Institute of the Novartis Research Foundation. In this role, he was responsible for development of hardware and assay technologies to support large-scale cellular profiling and high-throughput screening efforts. He is an active member of SLAS, served as co-chair of SLAS2012, and has chaired tracks and sessions at numerous scientific conferences in the past. Sipes holds an M.S. degree in immunology from the University of California, Davis, where he focused on molecular biology. He also holds a B.S. degree in molecular biology with a minor in chemistry from California State University, Sacramento.

Steve England, PhD

Chief Scientific Officer

Steven England joined as Chief Scientific Officer of Strateos in March 2018. Steve most recently worked at AbbVie, where he led a team focused on therapy development and emerging technology. His experience also includes drug discovery positions at AstraZeneca and Pfizer. Steve holds a Ph.D in Pharmacology from the University of Sheffield as well as a B.Sc in Pharmacology from the University of Sunderland.

Jimmy Sastra, PhD

Vice President, Automation

As an undergraduate at the University of Pennsylvania more than a decade ago, Jimmy Sastra worked in a traumatic brain injury lab where he learned that wet lab biology requires lots of tedious human labor and could greatly benefit from automation. This experience prompted him to get a PhD at the Penn Modlab, where he built modular robots. He then worked at Willow Garage, where Jimmy designed different body parts for a humanoid robot. He joined Strateos from the Open Source Robotics Foundation, where he worked in mechanical engineering.

Ben Miles, PhD

Head of Product

Ben Miles, Ph.D is a chemical biologist and product manager who has been working with Strateos since 2016. As product manager and a former customer of Strateos Ben works closely with our users and our internal team to ensure Strateos builds value for everyone of our users. As a scientist Ben is able to work closely with our users to understand their research requirements and synthesize those into the Strateos platform. Prior to Strateos, Ben worked in growth for the cloud-based electronic medical record company, Dentally, based in London, UK. Ben received a Ph.D and Master of Research in chemical biology from Imperial College London and also holds a B.Sc in Nanotechnology from the University of Leeds.

Yin He, PhD

Head of Scientific Operations

Yin He is Head of Scientific Operations and joined Strateos in June 2013 as the 2nd scientist. She holds a BS in Biology and Chemistry from the University of Virginia and a PhD in Molecular Biology, Genetics and Genomics from Cornell University. At Cornell, Yin’s thesis focused on protein folding pathways and endoplasmic reticulum (ER) stress in the context of metabolic disorders, resulting in 8 peer-reviewed publications in high-impact journals such as Cell Metabolism and Molecular Cell.

Chris Krueger

Chief Financial Officer

Chris Krueger joined Strateos in July of 2018 and brings more than 20 years of finance experience. In his current role he overseas all aspects of finance operations of the company. Previously, Chris served as SVP Finance and Operations at Vineti, a cloud based platform for the commercialization of cell & gene therapies, where he was responsible for the companies G&A organization. Prior to that role he served in multiple senior finance leadership roles at Grand Rounds, Flite (acquired by Snap), Avid Technologies and Digidesign. He started his career as a management trainee Mahle GmbH and later Siemens Semiconductor (now Infineon Technologies). Chris holds a bachelor of arts from the University of Michigan and a MBA from the Middlebury Institute of International Studies.

Kevin Sturdevant

Vice President, Business Operations

Kevin Sturdevant has more than a decade of experience in leading projects, products, and cross-functional teams in client-facing roles. His product experience includes learning management systems, mobile apps, and social media platforms while his project management experience includes delivering data workflow projects for Fortune 100 organizations. Prior to Strateos, Kevin led a Professional Services organization at Captricity, an Oakland-based SaaS product, and a Columbus, Ohio-based design and development agency.